Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001439222-25-000108
Filing Date
2025-10-10
Accepted
2025-10-10 16:18:07
Documents
1
Period of Report
2025-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1760127484.html 4  
1 FORM 4 wk-form4_1760127484.xml 4 6803
  Complete submission text file 0001439222-25-000108.txt   8281
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Issuer) CIK: 0001439222 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Scadden David (Reporting) CIK: 0001707715 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36014 | Film No.: 251388322